Theophylline/ephedra/hydroxyzine

Theophylline/ephedra/hydroxyzine
Combination of
TheophyllineStimulant
Ephedra (medicine)Stimulant
HydroxyzineAntihistamine
Clinical data
Trade namesMarax
AHFS/Drugs.comMicromedex Detailed Consumer Information
Routes of
administration		By mouth
ATC code
Identifiers
CAS Number
PubChem SID

Theophylline/ephedra/hydroxyzine (trade name Marax) is a drug that was used for the treatment of asthma. It was a combination of theophylline, ephedra,[1] and hydroxyzine, and taken by mouth.[2][3] It is no longer manufactured in the US due to approval of ephedra being withdrawn by the FDA.

See also

References

  1. ↑ Hunt TM (2011). Drug Games: The International Olympic Committee and the Politics of Doping, 1960–2008. University of Texas Press. p. 45. ISBN 978-0-292-73957-4. Retrieved 20 July 2018.
  2. ↑ Marax Micromedex Detailed Consumer Information. Accessed 23 April 2021.
  3. ↑ Fixley M, Shen DD, Azarnoff DL (June 1977). "Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline". The American Review of Respiratory Disease. 115 (6): 955–62. doi:10.1164/arrd.1977.115.6.955 (inactive 12 July 2025). PMID 262107.{{cite journal}}: CS1 maint: DOI inactive as of July 2025 (link)
This article is issued from WikiProjectMed. The text is available under Creative Commons Attribution-ShareAlike License unless otherwise noted. Additional terms may apply for the media files.